![Pierre Gagnon](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Pierre Gagnon
Keine laufenden Positionen mehr
Vermögen: - $ am 31.05.2024
Aktive Positionen von Pierre Gagnon
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ATGen Canada, Inc. | Direktor/Vorstandsmitglied | 01.05.2013 | - |
Karriereverlauf von Pierre Gagnon
Ehemalige bekannte Positionen von Pierre Gagnon
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
NKGen Biotech, Inc.
![]() NKGen Biotech, Inc. BiotechnologyHealth Technology NKGen Biotech, Inc. is a biotechnology company which engages in harnessing the immune system through natural killer cell therapies. It develops a proprietary stabilizing peptide, monoclonal antibodies, and recombinant proteins for research use. The company was founded in 2002 and is headquartered in Santa Ana, CA. | Direktor/Vorstandsmitglied | 01.11.2021 | - |
Geschäftsführer | 01.11.2021 | 01.09.2023 | |
NKMAX Co., Ltd.
![]() NKMAX Co., Ltd. Pharmaceuticals: MajorHealth Technology NKMAX Co., Ltd. engages in the manufacture and sale of pharmaceutical products. It operates through the following business divisions: Immunity Cell Cure, Immunodiagnosis Kit, Health Functional Foods, and Bio Research. The company was founded on January 14, 2002 and is headquartered in Seongnam-si, South Korea. | Direktor/Vorstandsmitglied | 01.03.2013 | 01.06.2019 |
Geschäftsführer | 01.08.2009 | 01.06.2019 |
Ausbildung von Pierre Gagnon
University of Quebec | Undergraduate Degree |
Statistik
International
Kanada | 3 |
Vereinigte Staaten | 2 |
Südkorea | 2 |
Operativ
Director/Board Member | 3 |
Chief Operating Officer | 3 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 3 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 3 |
---|---|
NKGen Biotech, Inc.
![]() NKGen Biotech, Inc. BiotechnologyHealth Technology NKGen Biotech, Inc. is a biotechnology company which engages in harnessing the immune system through natural killer cell therapies. It develops a proprietary stabilizing peptide, monoclonal antibodies, and recombinant proteins for research use. The company was founded in 2002 and is headquartered in Santa Ana, CA. | Health Technology |
NKMAX Co., Ltd.
![]() NKMAX Co., Ltd. Pharmaceuticals: MajorHealth Technology NKMAX Co., Ltd. engages in the manufacture and sale of pharmaceutical products. It operates through the following business divisions: Immunity Cell Cure, Immunodiagnosis Kit, Health Functional Foods, and Bio Research. The company was founded on January 14, 2002 and is headquartered in Seongnam-si, South Korea. | Health Technology |
ATGen Canada, Inc. |
- Börse
- Insiders
- Pierre Gagnon
- Erfahrung